Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
40.60
-0.53 (-1.29%)
At close: Jul 15, 2026
Market Cap4.45B +109.6%
Revenue (ttm)197.68M +1.8%
Net Income48.60M +4.3%
EPS0.54 +17.8%
Shares Out 108.22M
PE Ratio76.81
Forward PEn/a
Dividend0.38 (1.02%)
Ex-Dividend DateMay 29, 2026
Volume2,430,800
Open40.92
Previous Close41.13
Day's Range40.23 - 43.20
52-Week Range20.18 - 52.88
Beta0.47
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China. It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 330
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.79 million, an increase of 16.93%.

Financial Statements